238 related articles for article (PubMed ID: 26290064)
1. Topiramate augmentation in a patient with obsessive-compulsive disorder.
Van Ameringen M; Patterson B
J Psychiatry Neurosci; 2015 Sep; 40(5):E31-2. PubMed ID: 26290064
[No Abstract] [Full Text] [Related]
2. Topiramate plus paroxetine in treatment-resistant obsessive-compulsive disorder.
Hollander E; Dell'Osso B
Int Clin Psychopharmacol; 2006 May; 21(3):189-91. PubMed ID: 16528143
[TBL] [Abstract][Full Text] [Related]
3. Topiramate augmentation in treatment-resistant obsessive-compulsive disorder: a retrospective, open-label case series.
Van Ameringen M; Mancini C; Patterson B; Bennett M
Depress Anxiety; 2006; 23(1):1-5. PubMed ID: 16178009
[TBL] [Abstract][Full Text] [Related]
4. Topiramate related obsessive-compulsive disorder.
Ozkara C; Ozmen M; Erdogan A; Yalug I
Eur Psychiatry; 2005 Jan; 20(1):78-9. PubMed ID: 15642451
[No Abstract] [Full Text] [Related]
5. [Obsessive-compulsive disorders in general practice. How the obsessive-compulsive neurotic is revealed by skin and hair].
Kordon A; Broocks A; Hohagen F
MMW Fortschr Med; 2003 May; 145 Suppl 2():4-7. PubMed ID: 14579475
[TBL] [Abstract][Full Text] [Related]
6. Double-blind, placebo-controlled trial of topiramate augmentation in treatment-resistant obsessive-compulsive disorder.
Berlin HA; Koran LM; Jenike MA; Shapira NA; Chaplin W; Pallanti S; Hollander E
J Clin Psychiatry; 2011 May; 72(5):716-21. PubMed ID: 20816027
[TBL] [Abstract][Full Text] [Related]
7. Treatment of childhood obsessive-compulsive disorder with citalopram.
Maud C; Stein DJ
S Afr Med J; 1996 Jun; 86(6 Suppl):746, 748. PubMed ID: 9180769
[No Abstract] [Full Text] [Related]
8. Weight gain during long-term treatment of obsessive-compulsive disorder: a prospective comparison between serotonin reuptake inhibitors.
Maina G; Albert U; Salvi V; Bogetto F
J Clin Psychiatry; 2004 Oct; 65(10):1365-71. PubMed ID: 15491240
[TBL] [Abstract][Full Text] [Related]
9. Topiramate as an adjuvant treatment for obsessive compulsive symptoms in patients with bipolar disorder: a randomized double blind placebo controlled clinical trial.
Sahraian A; Bigdeli M; Ghanizadeh A; Akhondzadeh S
J Affect Disord; 2014 Sep; 166():201-5. PubMed ID: 25012432
[TBL] [Abstract][Full Text] [Related]
10. [Topiramate augmentation in treatment-resistant obsessive-compulsive disorder].
Vinkers DJ; van der Wee NJ
Tijdschr Psychiatr; 2008; 50(11):747-50. PubMed ID: 18991236
[TBL] [Abstract][Full Text] [Related]
11. Sertraline and obsessive compulsive disorder: new indication. Limited assessment.
Prescrire Int; 2000 Aug; 9(48):112-3. PubMed ID: 11067720
[TBL] [Abstract][Full Text] [Related]
12. High-dose escitalopram treatment in patients with obsessive-compulsive disorder: a naturalistic case series.
Shim GS; Kang DH; Kwon JS
J Clin Psychopharmacol; 2008 Feb; 28(1):108-10. PubMed ID: 18204356
[No Abstract] [Full Text] [Related]
13. Association of paroxetine with suicide attempt in obsessive-compulsive disorder.
Göder R; Friege L; Treskov V; Grohmann R; Aldenhoff JB
Pharmacopsychiatry; 2000 May; 33(3):116-7. PubMed ID: 10855464
[No Abstract] [Full Text] [Related]
14. Use of the selective serotonin reuptake inhibitor citalopram in a possible animal analogue of obsessive-compulsive disorder.
Stein DJ; Mendelsohn I; Potocnik F; Van Kradenberg J; Wessels C
Depress Anxiety; 1998; 8(1):39-42. PubMed ID: 9750979
[TBL] [Abstract][Full Text] [Related]
15. Carbamazepine for serotonin reuptake inhibitor nonresponder case of obsessive compulsive disorder.
Aggarwal A; Jain M; Garg A; Jiloha RC
Indian J Med Sci; 2009 Oct; 63(10):468-9. PubMed ID: 19901487
[No Abstract] [Full Text] [Related]
16. Efficacy of fluvoxamine, paroxetine, and citalopram in the treatment of obsessive-compulsive disorder: a single-blind study.
Mundo E; Bianchi L; Bellodi L
J Clin Psychopharmacol; 1997 Aug; 17(4):267-71. PubMed ID: 9241005
[TBL] [Abstract][Full Text] [Related]
17. Persistence, switching, and discontinuation rates among patients receiving sertraline, paroxetine, and citalopram.
Mullins CD; Shaya FT; Meng F; Wang J; Harrison D
Pharmacotherapy; 2005 May; 25(5):660-7. PubMed ID: 15899727
[TBL] [Abstract][Full Text] [Related]
18. Impulse control disorders in frontotemporal dementia: spectrum of symptoms and response to treatment.
Pompanin S; Jelcic N; Cecchin D; Cagnin A
Gen Hosp Psychiatry; 2014; 36(6):760.e5-7. PubMed ID: 25042130
[TBL] [Abstract][Full Text] [Related]
19. Psychogenic itch responding to topiramate.
Calabrò RS; Bramanti P; Digangi G; Mondello S; Italiano D
Psychosomatics; 2013; 54(3):297-300. PubMed ID: 23274005
[No Abstract] [Full Text] [Related]
20. Beyond depression: citalopram for obsessive-compulsive disorder.
Pato MT
Int Clin Psychopharmacol; 1999 May; 14 Suppl 2():S19-26. PubMed ID: 10471169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
